Literature DB >> 2183105

Transabdominal multifetal pregnancy reduction: report of 40 cases.

K M Tabsh1.   

Abstract

Forty patients with multiple gestations, all resulting from infertility treatment, underwent transabdominal multifetal pregnancy reduction at an average of 12 weeks' gestation. Twenty-three women with triplets, 13 with quadruplets, and four with quintuplets had their pregnancies reduced to twins, except for two (one reduced from five to three and one from three to one). Twenty-eight women have delivered and 12 have ongoing pregnancies; none of the 40 lost the entire pregnancy after the procedure. There was one neonatal death from prematurity, and one fetus died because of growth retardation. Ten (36%) delivered after 37 weeks' gestation, 16 (57%) between 33-36 weeks, and two (7%) before 33 weeks. No maternal complications directly related to the procedure were encountered. We conclude that selective termination is a safe procedure that may improve multifetal pregnancy outcome.

Entities:  

Mesh:

Year:  1990        PMID: 2183105

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Selective reduction of pregnancy: a legal analysis.

Authors:  A Hall
Journal:  J Med Ethics       Date:  1996-10       Impact factor: 2.903

2.  Embryo reduction: our experience.

Authors:  Pankaj Talwar; R K Sharma; K Sandeep; Shashi Sareen; B S Duggal
Journal:  Med J Armed Forces India       Date:  2011-08-07

3.  Successful management of heterotopic pregnancy after fetal reduction using potassium chloride and methotrexate.

Authors:  Deepika Deka; Anupama Bahadur; Aprajita Singh; Neena Malhotra
Journal:  J Hum Reprod Sci       Date:  2012-01

4.  Proliferation and Differentiation of Dopaminergic Neurons from Human Neuroepithelial Stem Cells Obtained from Embryo Reduction Following In Vitro Fertilization.

Authors:  Nguyen Thi Binh; Nguyen Khang Son; Dao Thuy Phuong; Do Thuy Huong; Nguyen Phuc Hoan; Nguyen Thanh Hoa; Nguyen Minh Duc; Nguyen Manh Ha
Journal:  Med Arch       Date:  2021-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.